RA
OCDX

Rise Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Rise Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,039
Closed -$225K – 747
2022
Q1 		$225K Buy
+12,039
New +$217K 0.2% 63

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Rise Advisors's OCDX Position: Q2 2022 in Review

Rise Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 12,039 shares — an estimated $225K sold.

Rise Advisors first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $225K in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Rise Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Rise Advisors sold 12,039 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $225K.
  • Rise Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Rise Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $225K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Rise Advisors's 13F filing for Q2 2022, filed 28 Jul 2022.